The earnings call highlighted positive developments in revenue growth and strategic initiatives but faced challenges with declining patient volumes and a decrease in EBITDA margin. The revised financial guidance reflects a cautious outlook due to external factors affecting healthcare demand.

Company Guidance

During the Community Health Systems second quarter 2025 earnings call, several metrics were highlighted regarding the company's performance and future outlook. The same-store net revenue increased by 6.5% year-over-year, while inpatient admissions rose by 0.3%. However, adjusted admissions declined by 0.7%, with surgeries decreasing by 2.5% and ER visits down by 1.9%. The adjusted EBITDA for the second quarter was reported at $380 million, down from $387 million in the prior year, with a margin of 12.1% versus 12.3% in the previous year. The company also reported year-to-date cash flows from operations at $208 million, which included $74 million in outflows for taxes on gains from sales. Looking ahead, the company tightened its full-year adjusted EBITDA guidance to a range of $1.45 billion to $1.55 billion due to lower-than-expected volume growth and strategic divestitures. Additionally, it was noted that the Budget Reconciliation Act could potentially reduce EBITDA by $300 million to $350 million over the next 13 years, although no impact is expected in 2025 or 2026.

Revenue Growth

Same-store net revenue increased 6.5% year-over-year, driven by rate growth including revenue recognition under Medicaid state-directed payment programs in New Mexico and Tennessee.

Debt Refinancing and Divestitures

CHS completed the divestiture of Cedar Park Regional Medical Center for $436 million and refinanced $700 million of 8% Senior Secured Notes, improving maturity and leverage profile.

Provider Recruitment and Expansion

Over 200 new providers are scheduled to start in the second half of 2025, with new outpatient access points set to open, including ambulatory surgery centers in key markets.

Community Health (CYH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CYH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 22, 2025	2025 (Q3)	-0.24 / -	-0.3	―	―	―
Jul 23, 2025	2025 (Q2)	-0.10 / -0.05	-0.17	70.59% (+0.12)
Apr 23, 2025	2025 (Q1)	-0.08 / -0.03	-0.14	78.57% (+0.11)
Feb 18, 2025	2024 (Q4)	0.08 / -0.42	-0.41	-2.44% (-0.01)
Oct 23, 2024	2024 (Q3)	-0.21 / -0.30	-0.33	9.09% (+0.03)
Jul 24, 2024	2024 (Q2)	-0.14 / -0.17	-0.22	22.73% (+0.05)
Apr 24, 2024	2024 (Q1)	-0.16 / -0.14	-0.43	67.44% (+0.29)
Feb 20, 2024	2023 (Q4)	0.05 / -0.41	1.5	-127.33% (-1.91)
Oct 25, 2023	2023 (Q3)	-0.16 / -0.33	-0.52	36.54% (+0.19)
Aug 02, 2023	2023 (Q2)	-0.26 / -0.22	-2.52	91.27% (+2.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CYH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 23, 2025	$3.88	$2.90	-25.26%
Apr 23, 2025	$2.43	$2.88	+18.52%
Feb 18, 2025	$3.35	$3.61	+7.76%
Oct 23, 2024	$5.55	$4.25	-23.42%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.